Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from ...

Celltrion’s biosimilar marketing strategy in Europe has got seriously confusing after the firm asked to market its rituximab near-copy under four different brands. Its biosimilar of Roche’s ...

Locally manufactured biologics include insulin, epoetin, filgrastim, streptokinase, and rituximab. Over 40 biologics are marketed in India, of which around 25 are biosimilars that are manufactured ...

Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new growth initiatives—and ...

Henlius (2696) held its 2025 Global R&D Day under the theme of "Collaborate to Create". Senior executives from Henlius gathered with leading experts, scholars, and heads of innovation from across the ...

Cancer Monoclonal Antibody Market Cancer rates continue to rise, especially in aging populations and areas affected by pollution and lifest ...

Retreatment with rituximab is beneficial ... Future therapies will hopefully include cheaper biosimilars, which have only been recently become available in some countries. Their approval and ...

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply ...

Pediatric patients receiving a combination of rituximab and cyclophosphamide therapy for rheumatic disease showed clinical improvement with a low risk for adverse effects. While current clinical ...

Greaves Cotton Limited, a diversified, multi-product engineering company with a legacy of 165 years, is pleased to announce ...

Nibe Space Private Limited gets the approval for registration with IN-SPACe for operations as a 'Data Disseminator' for the ...

TG Therapeutics' Briumvi has shown strong revenue growth, with $310 million in FY24, and is expected to reach $540 million in ...